Inventor
RZASA ROBERT M
US33 patents
⚠️ This page may combine multiple inventors who share the name “RZASA ROBERT M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
19 patentsUS7705018B2Apr 27, 2010
Substituted quinolines and their uses in treatment of inflammatory and related conditions
AMGEN INC51 citations97
US9611261B2Apr 4, 2017
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC25 citations94
US9085576B2Jul 21, 2015
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC31 citations94
US7700593B2Apr 20, 2010
Imidazo- and triazolo-pyridine compounds and methods of use thereof
AMGEN INC35 citations91
US9718803B2Aug 1, 2017
Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors
AMGEN INC8 citations84
US9303028B2Apr 5, 2016
Azetidine and piperidine compounds useful as PDE10 inhibitors
AMGEN INC4 citations84
US7919498B2Apr 5, 2011
Substituted pyrazolo[3,4-d]pyrimidines as PI3K inhibitors
AMGEN INC16 citations84
US7745449B2Jun 29, 2010
Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
AMGEN INC6 citations73
US9556135B2Jan 31, 2017
Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
AMGEN INC2 citations72
US9376450B2Jun 28, 2016
Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors
AMGEN INC4 citations72
US9174992B2Nov 3, 2015
Heterobicyclic compounds
AMGEN INC4 citations72
US8691986B2Apr 8, 2014
Azetidine and piperidine compounds useful as PDE10 inhibitors
AMGEN INC3 citations63
US9873701B2Jan 23, 2018
Heterocyclic compounds and their uses
AMGEN INC1 citations62
US9296734B2Mar 29, 2016
Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC2 citations62
US7759337B2Jul 20, 2010
Phthalazine compounds and methods of use
AMGEN INC7 citations61
US9493459B2Nov 15, 2016
Azetidine and piperidine compounds useful as PDE10 inhibitors
AMGEN INC0 citations52
US7314933B2Jan 1, 2008
Vanilloid receptor ligands and their use in treatments
AMGEN INC1 citations52
US9550762B2Jan 24, 2017
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC1 citations51
US8759532B2Jun 24, 2014
Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
AMGEN INC0 citations49
CHEN YI
6 patentsUS8193199B2Jun 5, 2012
Heterocyclic compounds and their uses
CHEN YI15 citations91
US8586739B2Nov 19, 2013
Heterocyclic compounds and their uses
CHEN YI13 citations83
US8901135B2Dec 2, 2014
Heterocyclic compounds and their uses
CHEN YI3 citations62
US8329910B2Dec 11, 2012
Quinolines for the treatment of PI3K-δ mediated diseases
CHEN YI3 citations62
US8183258B2May 22, 2012
Heterocyclic compounds and their uses
CHEN YI0 citations51
US8183259B2May 22, 2012
Heterocyclic compounds and their uses
CHEN YI0 citations51
ALLEN JENNIFER R
6 patentsUS8957073B2Feb 17, 2015
Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors
ALLEN JENNIFER R15 citations83
US8946230B2Feb 3, 2015
Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhibitors
ALLEN JENNIFER R5 citations71
US8497265B2Jul 30, 2013
Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors
ALLEN JENNIFER R4 citations62
US8637500B2Jan 28, 2014
Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
ALLEN JENNIFER R3 citations60
US8318718B2Nov 27, 2012
Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
ALLEN JENNIFER R4 citations60
US8952037B2Feb 10, 2015
Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
ALLEN JENNIFER R0 citations40